HCK and acute myeloid leukemia: To determine whether continued AML maintenance requires HCK, we crossed HCK−/− mice with FLP (H11-CAG-FLPO) mice and Rosa26-CreERT2 mice successively to generate HCKfl/fl /Rosa26-CreERT2 mice (Supplemental Fig. 1a, b).